Ercros, S.A. (BME:ECR)

Market Cap	310.43M +13.7%
Revenue (ttm)	598.53M -5.9%
Net Income	-55.04M
EPS	-0.60
Shares Out	91.44M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,485
Average Volume	18,745
Open	3.410
Previous Close	3.395
Day's Range	3.410 - 3.430
52-Week Range	2.230 - 3.475
Beta	0.25
RSI	47.92
Earnings Date	Feb 27, 2026

About Ercros

Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers. This segment's products are used as ...

• Industry: Chemicals
• Sector: Materials
• Founded: 1817
• Employees: 1,329
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ECR

Financial Performance

In 2025, Ercros's revenue was 628.69 million, a decrease of -5.92% compared to the previous year's 668.22 million. Losses were -53.59 million, 359.7% more than in 2024.